Back to search

Spain· ES:77481

TRECLINAC 10 MG/G + 0,25 MG/G GEL

A medicinal product containing clindamicina + tretinoína, registered in Spain by Viatris Healthcare Limited.

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedTRECLINAC 10 MG/G + 0,25 MG/G GELATC—REGISTER NO.ES:77481PACKS LISTED0CHECKEDSeptember 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
clindamicina + tretinoína
Manufacturer
Viatris Healthcare Limited
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Clindamicina + tretinoína in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All clindamicina + tretinoína products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Acnatac
  • Belgium · Treclinax
  • Bulgaria · Акнатак
  • Cyprus · Acnatac
  • Czechia · Acnatac
  • Germany · Acnatac
  • Denmark · Acnatac
  • Estonia · Treclinac
  • Finland · Acnatac
  • France · Zanea
  • United Kingdom (Northern Ireland) · Treclin
  • Greece · Acnatac, Treticlin
  • Ireland · Treclin
  • Iceland · Acnatac
  • Italy · Acnatac
  • Lithuania · Treclinac
  • Luxembourg · Treclinax
  • Latvia · Treclinac
  • Malta · Acnatac
  • Netherlands · Treclinac
  • Norway · Zalna
  • Poland · Acnatac
  • Portugal · Acnatac
  • Romania · Acnatac
  • Sweden · Acnatac
  • Slovenia · Zalna
  • Slovakia · Acnatac

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8c8ecca7-18d0-4753-b435-4eea9ded484a
GET /v1/drugs/8c8ecca7-18d0-4753-b435-4eea9ded484a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":1367272800000}",
  "nregistro": "77481",
  "substance": "clindamicina + tretinoína"
}

See everything about clindamicina + tretinoína.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.